| Literature DB >> 2816289 |
N Kamolvarin1, T Hemachudha, B Ongpipattanakul, P Phanuphak, P Viddayakorn, T Sueblinvong.
Abstract
Fast-migrating C3c, a sensitive index of complement activation, was assayed in the plasma of 2 myasthenia gravis (MG) patients in crisis who received high-dose IV immunoglobulin therapy. Dramatic responses were observed in both patients. Clinical improvement paralleled a decrement in C3c levels, suggesting that regulation of complement activation may be one possible mechanism of IV immunoglobulin treatment in MG.Entities:
Mesh：
Substances：
Year: 1989 PMID： 2816289 DOI： 10.1111/j.1600-0404.1989.tb03887.x
Source DB: PubMed Journal: Acta Neurol Scand ISSN： 0001-6314 Impact factor: 3.209